Found 4 results
[ Author(Desc)] Title Type Year
Filters: Author is Mutua, G  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
M
G. Mutua, Mutengu, L., Mpendo, J., Kilembe, W., Omosa, G., Ruzagirwa, E., Karita, E., Page-Shipp, L., Gray, G., Bekker, L. G., Barin, B., Schmidt, C., Laufer, D., and Priddy, F., Major Negative Social Impacts are Rare in Phase 1 HIV Vaccine Trials in Africa, in HIV Research for Prevention 2014: AIDS Vaccine, Microbicide and ARV-based Prevention Science (HIVR4P), Cape Town, SA, 2014.
G. Mutua, Sanders, E., Mugo, P., Anzala, O., Haberer, J. E., Bangsberg, D., Barin, B., Rooney, J. F., Mark, D., Chetty, P., Fast, P., and Priddy, F. H., Safety and Adherence to Intermittent Pre-Exposure Prophylaxis (PrEP) for HIV-1 in African Men Who Have Sex with Men and Female Sex Workers, PLoS One, vol. 7, p. e33103, 2012.
G. Mutua, Farah, B., Langat, R., Indangasi, J., Ogola, S., Onsembe, B., Kopycinski, J. T., Hayes, P., Borthwick, N. J., Ashraf, A., Dally, L., Barin, B., Tillander, A., Gilmour, J., De Bont, J., Crook, A., Hannaman, D., Cox, J. H., Anzala, O., Fast, P. E., Reilly, M., Chinyenze, K., Jaoko, W., and Hanke, T., Broad HIV-1 Inhibition in Vitro by Vaccine-Elicited CD8(+) T Cells in African Adults, Mol Ther Methods Clin Dev, vol. 3, no. 16061, p. 16061, 2016.
G. Mutua, Hanke, T., Fast, P., Hannaman, D., Chinyenze, K., Oino, G., Sajabi, R., Verlinde, C., Barin, B., Reilly, M., and Jaoko, W., Safety and Tolerability of pSG2.HIVconsv DNA MVA.HIVconsv and Ad35-GRIN Prime-Boost Combinations Administered to Healthy HIV-Uninfected Kenyan Adults, in HIV R4P 2016, Chicago, IL, 2016.